92953-12-3 Usage
Uses
Used in Biochemical Research:
2-Carboxyethyl Methanethiosulfonate is used as a reagent for probing the structures of important biological channels and transporters. Its ability to form mixed disulfides with thiols allows researchers to investigate the function and structure of these proteins in detail.
Used in the Study of ACh Receptor Channel:
In the field of neurobiology, 2-Carboxyethyl Methanethiosulfonate is used as a structural probe for the ACh (acetylcholine) receptor channel. This application helps researchers understand the mechanisms of neurotransmission and the role of ACh receptors in various physiological processes.
Used in the Study of GABA Receptor Channel:
2-Carboxyethyl Methanethiosulfonate is also utilized in the study of the GABA (gamma-aminobutyric acid) receptor channel, which plays a crucial role in inhibiting neuronal excitability. The reagent aids in elucidating the structural aspects of the GABA receptor channel and its involvement in regulating neuronal activity.
Used in the Study of Lactose Permease:
In the field of membrane transport, 2-Carboxyethyl Methanethiosulfonate is used as a probe for lactose permease, a protein responsible for the transport of lactose across the membrane. This application helps researchers gain insights into the transport mechanisms and the structural features of lactose permease.
Check Digit Verification of cas no
The CAS Registry Mumber 92953-12-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,9,5 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 92953-12:
(7*9)+(6*2)+(5*9)+(4*5)+(3*3)+(2*1)+(1*2)=153
153 % 10 = 3
So 92953-12-3 is a valid CAS Registry Number.
92953-12-3Relevant academic research and scientific papers
OCULAR PHARMACEUTICAL COMPOSITIONS
-
Page/Page column 25, (2009/10/22)
The present invention relates to novel derivatives of opthalmic compounds for the treatment of ocular diseases.
Cardiovascular agents
-
Page/Page column 10, (2008/12/04)
The present invention relates to novel compounds that are derivatives of angiotensin receptor blocker (ARB) that comprise in their formula a polysulfurated group and that are useful for treating cardio-vascular diseases, such as hypertension, ischemic heart disease, atherosclerosis, metabolic syndrome, etc. also in combination with other cardiovascular agents.
5-Fluorouracil derivatives and their use for the treatment of cancer
-
Page/Page column 5, (2008/12/06)
The present invention relates to 5-fluoropyrimidine compounds of formula I that are useful for preventing, treating or reducing tumoral diseases and pathological conditions involving various cancer forms.
Anti-inflammatory agents
-
Page/Page column 4, (2008/06/13)
The present invention relates to novel thiosulfonates derivatives. The present invention also provides methods for preventing, treating and/or reducing inflammation-associated diseases in the cardiovascular, connective tissue, pulmonary, gastrointestinal, respiratory, urogenital, nervous or cutaneous systems as well as infective and tumoral diseases employing said compounds.
Linker compounds, linker-compound-ligands and linker-compound-receptors
-
, (2008/06/13)
Novel immunoassay which utilizes an enzyme linked ligand or receptor wherein the enzyme is bacterial luciferase; mercantile kit useful in performing said immunoassay; and compounds utilized in performing said assay.
